From pills to new uses, here's what Eli Lilly’s top scientist sees as the future of weight loss drugs ○
found
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Eli Lilly Chief Scientific Officer Dan Skovronsky spoke to CNBC about obesity pills and more on the future of weight loss.